Cargando…
Oncolytic adenovirus inhibits malignant ascites of advanced ovarian cancer by reprogramming the ascitic immune microenvironment
Malignant ascites frequently occur in patients with advanced ovarian cancer at initial diagnosis, and in almost all cases of relapse, they are closely related to poor prognosis, chemoresistance, and metastasis. To date, effective management strategies have been limited. In this study, we aimed to in...
Autores principales: | Shi, Gang, Shi, Pengyi, Yu, Yan, Xu, Jia, Ma, Jinhu, Zhang, Yong, Dong, Zhexu, Shen, Lanlin, Dai, Lei, Cheng, Lin, Cheng, Ping, Deng, Hongxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637216/ https://www.ncbi.nlm.nih.gov/pubmed/34901391 http://dx.doi.org/10.1016/j.omto.2021.11.008 |
Ejemplares similares
-
Oncolytic adenovirus for treatment of malignant ascites
por: Hemminki, Akseli, et al.
Publicado: (2022) -
Ascites Volumes and the Ovarian Cancer Microenvironment
por: Penet, Marie-France, et al.
Publicado: (2018) -
Immune Tumor Microenvironment in Ovarian Cancer Ascites
por: Almeida-Nunes, Diana Luísa, et al.
Publicado: (2022) -
Oncolytic Adenovirus-Loaded Menstrual Blood Stem Cells Overcome the Blockade of Viral Activity Exerted by Ovarian Cancer Ascites
por: Alfano, Ana Laura, et al.
Publicado: (2017) -
Management of non-ovarian cancer malignant ascites through indwelling catheter drainage
por: Gu, Xiaoli, et al.
Publicado: (2016)